Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far
Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed product is threatening to hamper Europe’s Covid-19 immunisation programme.
The vaccine, subject of an acrimonious tug-of-war between its British-Swedish manufacturer and the European commission last month, is now being described by German media as a “shelf warmer” as only around 17% of doses delivered to the country have been administered so far.
Related: A quarter of people in France, Germany and the US may refuse Covid vaccine
Related: AstraZeneca to build new Covid-19 vaccine facility in Germany
